In 1979, Deng Xiaoping drew "a circle" on the shore of the South China Sea.
Forty years later, this once-obscure "small fishing village" of Shenzhen has leapt forward to become one of China's central economic cities, a national innovative city, and an international science, technology, and industrial innovation center.
This is thanks to Shenzhen's gathering of remarkable people and innovation-driven development.
Hu Xiang, founder of Beike Biotech, is one of these remarkable people.
On January 14, 2019, Dr. Hu Xiang, Chairman of Beike Biotech, attended the awards ceremony of the 5th Shenzhen Merchants Global Conference and was named one of the 2018 "11th Shenzhen Merchants of Distinction".
Dr. Hu Xiang, Chairman of Beike Biotech, attended the awards ceremony of the 5th Shenzhen Merchants Global Conference and was named one of the 2018 "11th Shenzhen Merchants of Distinction".
He also delivered a keynote speech at the conference's "Backbone of a Great Nation, Spirit of Craftsmanship — Manufacturing Forum", showcasing the leadership and stature of a Shenzhen entrepreneur with influence across China!
Under the keynote theme "Backbone of a Great Nation, Spirit of Craftsmanship, Life Manufacturing and Manufacturing with Life", Dr. Hu Xiang led the audience into a new era of life science. Today, humanity's reach has extended into our own previously unknown territory — cells, stem cells, and the regenerative medicine that emerges from them. The following are excerpts from Dr. Hu Xiang's outstanding speech:
"In the future, treating disease will not depend on chemical drugs; instead, we will mainly use our own cells to treat ourselves. Cell therapy will become a pillar of the medicine of the future.
Manufacturing with life is the spirit of craftsmanship. People may think that producing one batch of cells is simple — that you can hum a tune in the lab and the cells will grow. But it is not so. To do this for tens of thousands or millions of people in a way that is reproducible and trouble-free, you must build a complete quality control system. For every batch of cells stored at the Shenzhen Cell Preparation Center, there are 580+ standard documents, 740+ quality records, and up to 910+ quality control checkpoints with testing or confirmation. We must build this standard and system, and drive industry development."
Authoritative third-party certifications obtained by Beike Biotech in the bio industry
Beike Biotech has dedicated itself to the cell field for thirteen years, with a strong R&D team in the field. To date, it has filed 85 patent applications in biomedicine, 40 of which have been granted; undertaken 66 national, provincial, and municipal research projects, including 863 Program projects and Torch Program projects; and published more than 100 papers in journals such as Cell Stem Cell.
In December 2015, the National Development and Reform Commission approved Beike Biotech to undertake the construction of the "National and Local Joint Engineering Laboratory for Personalized Cell Therapy Technology", which is a national-level technology development and translation platform driving the clinical translation of personalized cell therapy technologies in China.
